["{\"step_by_step_thinking\": \"Acetazolamide is a non-competitive inhibitor of carbonic anhydrase enzyme. This means it will bind to the enzyme at a site other than the active site, effectively reducing its activity. Since carbonic anhydrase plays a role in regulating intraocular pressure, inhibiting it would be expected to increase intraocular pressure. The question is about angle closure glaucoma, which requires decreasing intraocular pressure. Therefore, we need an effect that would decrease Vmax (maximum velocity of the enzyme reaction) or at least not increase it.\n\nLooking at the options, a non-competitive inhibitor would typically decrease Vmax without affecting Km (Michaelis constant), so option D: No change in Vmax is unlikely.\n\nA competitive inhibitor would bind to the active site and increase Km, but not Vmax. This is also unlikely since we need an effect that decreases intraocular pressure.\n\nB: Decrease in Km would mean the enzyme is less efficient at low substrate concentrations, which doesn't fit our goal of decreasing intraocular pressure.\n\nThe only option left is C: Decrease in both Km and Vmax. However, this would mean the enzyme is less efficient at all substrate concentrations, including high ones where the effect might be beneficial.\n\nGiven that acetazolamide is used to decrease intraocular pressure in angle closure glaucoma, we need an effect that decreases Vmax without affecting Km or leaving it unchanged.\", \"answer_choice\": C}"]